Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation

被引:9
作者
Blustin, Jodi M. [1 ]
McBane, Robert D. [1 ]
Ketha, Siva S. [1 ,2 ]
Wysokinski, Waldemar E. [1 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Gonda Vasc Ctr, 200 First St,SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Cardiovasc Dis, Jacksonville, FL 32224 USA
关键词
distribution; non-valvular atrial fibrillation; risk factors; thromboembolism; valvular atrial fibrillation;
D O I
10.1586/14779072.2014.960851
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most feared consequence of atrial fibrillation (AF) is thromboembolism, either to the brain causing stroke or to the non-cerebral circulation. Valvular atrial fibrillation (VAF) and non-valvular atrial fibrillation (NVAF) differ not only by morphological substrate of arrhythmia but also by the rate of thromboembolic complications, predisposing factors and destination of embolism. In the setting of VAF, there is a higher risk of thromboembolism and a higher prevalence of thrombus location within the body of the left atrium compared to NVAF. VAF is also associated with a proportionally higher propensity for non-cerebral thromboemboli than in NVAF. The distribution of non-cerebral thromboemboli appears to be similar in VAF and NVAF; however, more research needs to be done in this area, particularly with regard to VAF.
引用
收藏
页码:1129 / 1132
页数:4
相关论文
共 25 条
[1]   Left Atrial Blood Stasis and Von Willebrand Factor-ADAMTS13 Homeostasis in Atrial Fibrillation [J].
Ammash, Naser ;
Konik, Ewa A. ;
McBane, Robert D. ;
Chen, Dong ;
Tange, Julie I. ;
Grill, Diane E. ;
Herges, Regina M. ;
McLeod, Thomas G. ;
Friedman, Paul A. ;
Wysokinski, Waldemar E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (11) :2760-2766
[2]  
Cannegieter SC, 1994, CIRCULATION
[3]   5 TO 8-YEAR FOLLOW-UP OF PATIENTS UNDERGOING PORCINE HEART-VALVE REPLACEMENT [J].
COHN, LH ;
MUDGE, GH ;
PRATTER, F ;
COLLINS, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (05) :258-262
[4]  
COULSHED N, 1970, BRIT HEART J, V32, P26
[5]   Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation - The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study [J].
Fang, MC ;
Singer, DE ;
Chang, YC ;
Hylek, EM ;
Henault, LE ;
Jensvold, NG ;
Go, AS .
CIRCULATION, 2005, 112 (12) :1687-1691
[6]   Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation [J].
Frost, L ;
Engholm, G ;
Johnsen, S ;
Moller, H ;
Henneberg, EW ;
Husted, S .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (02) :272-276
[7]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870
[8]   Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation - Analysis of 2012 participants in the SPAF I-III clinical trials [J].
Hart, RG ;
Pearce, LA ;
McBride, R ;
Rothbart, RM ;
Asinger, RW .
STROKE, 1999, 30 (06) :1223-1229
[9]   Subclinical Atrial Fibrillation and the Risk of Stroke [J].
Healey, Jeff S. ;
Connolly, Stuart J. ;
Gold, Michael R. ;
Israel, Carsten W. ;
Van Gelder, Isabelle C. ;
Capucci, Alessandro ;
Lau, C. P. ;
Fain, Eric ;
Yang, Sean ;
Bailleul, Christophe ;
Morillo, Carlos A. ;
Carlson, Mark ;
Themeles, Ellison ;
Kaufman, Elizabeth S. ;
Hohnloser, Stefan H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :120-129
[10]   Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study [J].
Heeringa, J ;
van der Kuip, DAM ;
Hofman, A ;
Kors, JA ;
van Herpen, G ;
Stricker, BHC ;
Stijnen, T ;
Lip, GYH ;
Witteman, JCM .
EUROPEAN HEART JOURNAL, 2006, 27 (08) :949-953